The historical development and economic impact of pharmaceuticals in the UK are nowadays reasonably well documented. That industry has become the most profitable and fast growing of the country's high-tech industries. Its member firms undertake more than one-fifth of the national research and development (R&D) activities, one half being carried out in Britain, and currently achieve a £2.4 billion favourable trade balance with the rest of the world.